作者
Malcolm Lader, Andre Tylee, John Donoghue
发表日期
2009/1
来源
CNS drugs
卷号
23
页码范围
19-34
出版商
Springer International Publishing
简介
The use of benzodiazepine anxiolytics and hypnotics continues to excite controversy. Views differ from expert to expert and from country to country as to the extent of the problem, or even whether long-term benzodiazepine use actually constitutes a problem. The adverse effects of these drugs have been extensively documented and their effectiveness is being increasingly questioned. Discontinuation is usually beneficial as it is followed by improved psychomotor and cognitive functioning, particularly in the elderly. The potential for dependence and addiction have also become more apparent. The licensing of SSRIs for anxiety disorders has widened the prescribers’ therapeutic choices (although this group of medications also have their own adverse effects). Melatonin agonists show promise in some forms of insomnia. Accordingly, it is now even more imperative that long-term benzodiazepine users be …
引用总数
2008200920102011201220132014201520162017201820192020202120222023202419242324273320312523261430251411
学术搜索中的文章